secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMGEN INC (AMGN)
CIK:        0000318154
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001193125-23-227040
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amgen and Horizon resolve FTC lawsuit; consent order clears path to close acquisition in early Q4 2023
--------------------------------------------------------------------------------

- Consent order agreement with FTC resolves pending administrative lawsuit related to Amgen's acquisition of Horizon.
- Parties will jointly file to dismiss preliminary injunction motion and dissolve TRO in U.S. District Court for Northern District of Illinois.
- Amgen gave narrow assurance it has no intention or ability to bundle Horizon's TEPEZZA or KRYSTEXXA; no impact on business.
- Acquisition expected to close in early Q4 2023, pending final approvals under Irish law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318154/000119312523227040/0001193125-23-227040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318154/000119312523227040/d525571d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-227040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer